Skip to main content

Articles

Page 53 of 62

  1. The most common apolipoprotein E (apoE) gene polymorphism has been found to influence plasma lipid concentration and its correlation with coronary artery disease (CAD) has been extensively investigated in the ...

    Authors: Rajesh Chaudhary, Atip Likidlilid, Thavatchai Peerapatdit, Damras Tresukosol, Sorachai Srisuma, Suphachai Ratanamaneechat and Charn Sriratanasathavorn
    Citation: Cardiovascular Diabetology 2012 11:36
  2. Health utility (HU) measures are used as overall measures of quality of life and to determine quality adjusted life years (QALYs) in economic analyses. We compared baseline values of three HUs including Short ...

    Authors: Dennis W Raisch, Patricia Feeney, David C Goff Jr, KM Venkat Narayan, Patrick J O’Connor, Ping Zhang, Don G Hire and Mark D Sullivan
    Citation: Cardiovascular Diabetology 2012 11:35
  3. Since betaine is an osmolyte and methyl donor, and abnormal betaine loss is common in diabetes mellitus (>20% patients), we investigated the relationship between betaine and the post-methionine load rise in ho...

    Authors: Michael Lever, Sandy Slow, David O McGregor, Warwick J Dellow, Peter M George and Stephen T Chambers
    Citation: Cardiovascular Diabetology 2012 11:34
  4. A higher increase in intracellular Na+ via Na+/H+ exchanger (NHE) during ischemia has been reported in type 2 diabetic mouse hearts. We investigated the role of NHE in inducing changes in cytoplasmic Ca2+ concent...

    Authors: Ryuko Anzawa, Shingo Seki, Tomohisa Nagoshi, Ikuo Taniguchi, Danielle Feuvray and Michihiro Yoshimura
    Citation: Cardiovascular Diabetology 2012 11:33
  5. Hypertension has a major associated risk for organ damage and mortality, which is further heightened in patients with prior cardiovascular (CV) events, comorbid diabetes mellitus, microalbuminuria and renal im...

    Authors: Samir G Mallat
    Citation: Cardiovascular Diabetology 2012 11:32
  6. The metabolic syndrome is associated with increased risk for both diabetes and coronary artery disease, which insulin resistance alone does not satisfactorily explain. We propose an additional and complementar...

    Authors: Surujpal Teelucksingh, Sarada Jaimungal, Lexley Pinto Pereira, Terence Seemungal and Shivananda Nayak
    Citation: Cardiovascular Diabetology 2012 11:31
  7. Indigenous populations of Australia and Canada experience disproportionately high rates of chronic disease. Our goal was to compare cardiovascular (CVD) risk profile and diabetes complications from three recen...

    Authors: Louise J Maple-Brown, Joan Cunningham, Bernard Zinman, Mary Mamakeesick, Stewart B Harris, Philip W Connelly, Jonathan Shaw, Kerin O'Dea and Anthony J Hanley
    Citation: Cardiovascular Diabetology 2012 11:30
  8. The hypoglycemic effect of bezafibrate is well established, but administration to a large population of patients with diabetes has not been reported. We investigated glycemic control, relationship between lipi...

    Authors: Tamio Teramoto, Kohji Shirai, Hiroyuki Daida and Nobuhiro Yamada
    Citation: Cardiovascular Diabetology 2012 11:29
  9. The current study was carried out to determine whether fasudil hydrochloride (fasudil), a Rho-kinase inhibitor, has myocardial postconditioning (PostC) activity under hyperglycemia as well as normoglycemia, an...

    Authors: Taiga Ichinomiya, Sungsam Cho, Ushio Higashijima, Shuhei Matsumoto, Takuji Maekawa and Koji Sumikawa
    Citation: Cardiovascular Diabetology 2012 11:28
  10. The leading cause of death for patients suffering from diabetes is macrovascular disease. Endothelial dysfunction is often observed in type 2 diabetic patients and it is considered to be an important early eve...

    Authors: Linnéa Eriksson, Özlem Erdogdu, Thomas Nyström, Qimin Zhang and Åke Sjöholm
    Citation: Cardiovascular Diabetology 2012 11:27
  11. Chronic kidney disease (CKD) is associated with cardiovascular events. Adipocyte fatty acid-binding protein (A-FABP) plays an important role in atherosclerosis. We investigated whether plasma A-FABP is involve...

    Authors: Mutsumi Iwamoto, Toru Miyoshi, Masayuki Doi, Ko Takeda, Masahito Kajiya, Kazumasa Nosaka, Rie Nakayama, Satoshi Hirohata, Shinichi Usui, Shozo Kusachi, Kosuke Sakane, Kazuhfumi Nakamura and Hiroshi Ito
    Citation: Cardiovascular Diabetology 2012 11:26
  12. People with central obesity have an increased risk for developing the metabolic syndrome, type 2 diabetes and cardiovascular disease. However, a substantial part of obese individuals have no other cardiovascul...

    Authors: Corine den Engelsen, Paula S Koekkoek, Kees J Gorter, Maureen van den Donk, Philippe L Salomé and Guy E Rutten
    Citation: Cardiovascular Diabetology 2012 11:25
  13. Cardiac autonomic neuropathy (CAN) is a common complication of diabetes associated with poor prognosis. In addition, the autonomic imbalance is associated with cardiovascular disease (CVD) in diabetes. It is t...

    Authors: Chan-Hee Jung, Bo-Yeon Kim, Chul-Hee Kim, Sung-Koo Kang, Sang-Hee Jung and Ji-Oh Mok
    Citation: Cardiovascular Diabetology 2012 11:24
  14. Premature ventricular complexes (PVC) predict cardiovascular mortality among several adult populations. Increased arrhythmia prevalence has been reported during controlled magnesium (Mg) depletion studies in a...

    Authors: Liana C Del Gobbo, Yiqing Song, Paul Poirier, Eric Dewailly, Ronald J Elin and Grace M Egeland
    Citation: Cardiovascular Diabetology 2012 11:23
  15. B-type natriuretic peptide (BNP), a member of the natriuretic peptide family, is a cardiac-derived secretory hormone with natriuretic, diuretic, and vasorelaxant activities. Intraabdominal fat accumulation is ...

    Authors: Hideaki Nakatsuji, Ken Kishida, Tohru Funahashi, Tohru Nakagawa and Iichiro Shimomura
    Citation: Cardiovascular Diabetology 2012 11:22
  16. Meta-analysis has demonstrated an exponential relationship between 2-hr postchallenge hyperglycemia and coronary artery disease (CAD). Pulsatile hyperglycemia can acutely increase proinflammatory cytokines by ...

    Authors: Chih-Sheng Chu, Kun-Tai Lee, Kai-Hong Cheng, Min-Yi Lee, Hsuan-Fu Kuo, Tsung-Hsien Lin, Ho-Ming Su, Wen-Chol Voon, Sheng-Hsiung Sheu and Wen-Ter Lai
    Citation: Cardiovascular Diabetology 2012 11:21
  17. Visceral adiposity index (VAI) has recently been suggested to be used as a surrogate of visceral adiposity. We examined if VAI could improve predictive performances for CVD of the Framingham's general CVD algo...

    Authors: Bozorgmanesh Mohammadreza, Hadaegh Farzad, Khalili Davoud and Azizi Fereidoun Prof
    Citation: Cardiovascular Diabetology 2012 11:20
  18. Intensive multifactorial treatment aimed at prevention of cardiovascular (CV) disease may reduce left ventricular (LV) echocardiographic abnormalities in diabetic subjects. Plasma N-terminal (NT)-proBNP predic...

    Authors: Henrik Reinhard, Peter R Hansen, Niels Wiinberg, Andreas Kjær, Claus L Petersen, Kaj Winther, Hans-Henrik Parving, Peter Rossing and Peter K Jacobsen
    Citation: Cardiovascular Diabetology 2012 11:19
  19. Lower extremity amputations are costly and debilitating complications in patients with diabetes mellitus (DM). Our aim was to investigate changes in the amputation rate in patients with DM at the Karolinska Un...

    Authors: Alexandra Alvarsson, Buster Sandgren, Carl Wendel, Michael Alvarsson and Kerstin Brismar
    Citation: Cardiovascular Diabetology 2012 11:18
  20. The purpose of this study was to assess the efficacy of interventional therapy for peripheral arterial occlusive disease and the difference between diabetic patients and non-diabetic patients.

    Authors: Liang Xiao, De-sheng Huang, Jia-jie Tong and Jing Shen
    Citation: Cardiovascular Diabetology 2012 11:17
  21. People of different racial and ethnic backgrounds have a distinct pattern of central fat deposition, thus making it necessary to devise a race based approach for the diagnosis and evaluation of abdominal obesi...

    Authors: Aibek E Mirrakhimov, Olga S Lunegova, Alina S Kerimkulova, Cholpon B Moldokeeva, Malik P Nabiev and Erkin M Mirrakhimov
    Citation: Cardiovascular Diabetology 2012 11:16
  22. Generalized arterial alterations, such as endothelial dysfunction, medial matrix accumulations, and calcifications are associated with type 2 diabetes (T2D). These changes may render the vessel wall more susce...

    Authors: Vibe Skov, Steen Knudsen, Malene Olesen, Maria L Hansen and Lars M Rasmussen
    Citation: Cardiovascular Diabetology 2012 11:15
  23. The prognostic benefits of beta-blockers (BB) in patients with systolic heart failure (SHF) are known but despite this, in patients with diabetes they are underutilized. The aim of this study was to assess the...

    Authors: Bryan Wai, Leighton G Kearney, David L Hare, Michelle Ord, Louise M Burrell and Piyush M Srivastava
    Citation: Cardiovascular Diabetology 2012 11:14
  24. The aim of this study is to investigate the relationships between HbA1c and other risk factors like obesity, functional fitness, lipid profile, and inflammatory status in older adults. Epidemiological evidence...

    Authors: Raul A Martins, John G Jones, Sean P Cumming, Manuel J Coelho e Silva, Ana M Teixeira and Manuel T Veríssimo
    Citation: Cardiovascular Diabetology 2012 11:13
  25. The decrease and dysfunction of endothelial progenitor cells (EPCs) has been assumed as an important cause/consequence of diabetes mellitus (DM) and its complications, in which the senescence of EPCs induced b...

    Authors: Zhiyong Yin, Linni Fan, Gaosheng Huang, Haichang Wang and Zhe Wang
    Citation: Cardiovascular Diabetology 2012 11:12
  26. Lipocalin-2 is a novel adipokine with connection to insulin resistance. In this study, we aimed to investigate the association of serum lipocalin-2 with glucose metabolism and other metabolic phenotype in a la...

    Authors: Ying Huang, Zhen Yang, Zi Ye, Qin Li, Jie Wen, Xiaoming Tao, Lili Chen, Min He, Xuanchun Wang, Bin Lu, Zhaoyun Zhang, Weiwei Zhang, Shen Qu and Renming Hu
    Citation: Cardiovascular Diabetology 2012 11:11
  27. The role of Lipoprotein (a) cholesterol {Lp(a)-C}as an additional and/or independent risk factor for cardiovascular disease (CVD) is not clear. We evaluated the associations between Lp(a)-C and other CVD risk ...

    Authors: Sushma Sharma, Jayshree Merchant and Sharon E Fleming
    Citation: Cardiovascular Diabetology 2012 11:10
  28. An impairment of cardiovascular function in streptozotocin (STZ)-diabetic rats has been mentioned within 5 days-to-3 months of induction. ATP-sensitive potassium (KATP) channels are expressed on cardiac sarcolemm...

    Authors: Zhih-Cherng Chen, Yung-Ze Cheng, Li-Jen Chen, Kai-Chun Cheng, Yin- Xiao Li and Juei- Tang Cheng
    Citation: Cardiovascular Diabetology 2012 11:8
  29. The role of advanced glycation end products (AGEs) in the development of diabetes, especially diabetic complications, has been emphasized in many reports. Accumulation of AGEs in the vasculature triggers a ser...

    Authors: Jiping Wang, Hongxia Liu, Bo Chen, Qiang Li, Xuliang Huang, Liqun Wang, Xiaohua Guo and Qiaobing Huang
    Citation: Cardiovascular Diabetology 2012 11:7
  30. Adiposity greatly increases the risk of atherothrombotic events, a pathological condition where a chronic state of oxidative stress is reported to play a major role. This study aimed to investigate the involve...

    Authors: Priscila F Monteiro, Rafael P Morganti, Maria A Delbin, Marina C Calixto, Maria E Lopes-Pires, Sisi Marcondes, Angelina Zanesco and Edson Antunes
    Citation: Cardiovascular Diabetology 2012 11:5
  31. The authors examined whether milrinone and levosimendan could exert cardiac postconditioning effects in rats under normoglycemia and hyperglycemia, and whether the effects could be mediated by mitochondrial pe...

    Authors: Shuhei Matsumoto, Sungsam Cho, Shinya Tosaka, Ushio Higashijima, Takuji Maekawa, Tetsuya Hara and Koji Sumikawa
    Citation: Cardiovascular Diabetology 2012 11:4
  32. This study investigated the cardiovascular (CV) safety profile of the dipeptidyl peptidase (DPP)-4 inhibitor linagliptin versus comparator treatments.

    Authors: Odd Erik Johansen, Dietmar Neubacher, Maximilian von Eynatten, Sanjay Patel and Hans-Juergen Woerle
    Citation: Cardiovascular Diabetology 2012 11:3
  33. Carotid intima-media thickness (IMT) is an useful surrogate marker of cardiovascular disease. Associations between uric acid (UA), metabolic syndrome (MetS) and carotid IMT have been reported, but findings reg...

    Authors: Shuzo Takayama, Ryuichi Kawamoto, Tomo Kusunoki, Masanori Abe and Morikazu Onji
    Citation: Cardiovascular Diabetology 2012 11:2
  34. Previous randomized controlled trials demonstrated a protective effect of renin angiotensin system blocking agents for the development of type-2 diabetes in patients with pre-diabetes. However, there are no re...

    Authors: Walter Zidek, Joachim Schrader, Stephan Lüders, Stephan Matthaei, Christoph Hasslacher, Joachim Hoyer, Claudia Zemmrich, Peter Bramlage, Claus-Dieter Sturm and W Dieter Paar
    Citation: Cardiovascular Diabetology 2012 11:1
  35. The increased risk of cardiovascular disease (CVD) in diabetic compared to non-diabetic subjects seems to decrease with age. Whether this age-related reduction applies to CVD risk factors, and whether it is li...

    Authors: Margret Leosdottir, Ronnie Willenheimer, Margaretha Persson and Peter M Nilsson
    Citation: Cardiovascular Diabetology 2011 10:118
  36. Type 2 diabetes mellitus (T2DM) is associated with an increased risk of atherosclerotic vascular disease, but it is unknown whether the other way around is true too. C57BL/6 (B6) and BALB/cJ (BALB) are two mou...

    Authors: Jing Li, Qian Wang, Weidong Chai, Mei-Hua Chen, Zhenqi Liu and Weibin Shi
    Citation: Cardiovascular Diabetology 2011 10:117
  37. This study investigates the associations between changes in serum Triglycerides (S-TG), -Urate (S-Urate), and -Glucose (S-Glu) and changes in serum Calcium (S-Ca), -Magnesium (S-Mg), and -Phosphate (S-P) in pa...

    Authors: Lena Håglin, Lennart Bäckman and Birgitta Törnkvist
    Citation: Cardiovascular Diabetology 2011 10:116
  38. Glucose fluctuations including robust postprandial hyperglycemia are a risk for promoting atherosclerosis and diabetic complications. The α-glucosidase inhibitors and the dipeptidyl peptidase-4 (DPP-4) inhibit...

    Authors: Miyako Kishimoto and Mitsuhiko Noda
    Citation: Cardiovascular Diabetology 2011 10:115
  39. Accumulating evidence suggests that cytochrome P450 (CYP) epoxygenases metabolize arachidonic acid into epoxyeicosatrienoic acids (EETs) which play important roles in various pathophysiological processes. Inte...

    Authors: Xizhen Xu, Ling Tu, Luyun Wang, Xiaosai Fang and Dao Wen Wang
    Citation: Cardiovascular Diabetology 2011 10:114

    The Erratum to this article has been published in Cardiovascular Diabetology 2014 13:17

  40. Patients with type 2 diabetes mellitus (DM) have increased risk of endothelial dysfunction and arterial stiffness. Levels of circulating endothelial progenitor cells (EPCs) are also reduced in hyperglycemic st...

    Authors: Wen-Sheng Yue, Kui-Kai Lau, Chung-Wah Siu, Mei Wang, Guo-Hui Yan, Kai-Hang Yiu and Hung-Fat Tse
    Citation: Cardiovascular Diabetology 2011 10:113
  41. Metabolic Syndrome (MetS) results from the combined effect of environmental and genetic factors. We investigated the possible association of peroxisome proliferator-activated receptor-γ2 (PPARγ2) Pro12Ala and ...

    Authors: Angela Passaro, Edoardo Dalla Nora, Caterina Marcello, Francesca Di Vece, Mario Luca Morieri, Juana M Sanz, Cristina Bosi, Renato Fellin and Giovanni Zuliani
    Citation: Cardiovascular Diabetology 2011 10:112
  42. In the general population, peripheral metabolic complications (MC) increase the risk for left ventricular dysfunction. Human immunodeficiency virus infection (HIV) and combination anti-retroviral therapy (cART...

    Authors: W Todd Cade, Dominic N Reeds, E Turner Overton, Pilar Herrero, Alan D Waggoner, Victor G Davila-Roman, Sherry Lassa-Claxton, Robert J Gropler, Pablo F Soto, Melissa J Krauss, Kevin E Yarasheski and Linda R Peterson
    Citation: Cardiovascular Diabetology 2011 10:111
  43. Increased IL-18 serum levels have been associated with diabetes type 2, metabolic syndrome and the severity of atherosclerosis. The present study investigated the presence and influence of IL-18 genetic varian...

    Authors: Trine B Opstad, Alf Å Pettersen, Harald Arnesen and Ingebjørg Seljeflot
    Citation: Cardiovascular Diabetology 2011 10:110
  44. To examine the effects of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on visceral fat adiposity, appetite, food preference, and biomarkers of cardiovascular system in Japanese patients with type 2...

    Authors: Kana Inoue, Norikazu Maeda, Susumu Kashine, Yuya Fujishima, Junji Kozawa, Aki Hiuge-Shimizu, Kohei Okita, Akihisa Imagawa, Tohru Funahashi and Iichiro Shimomura
    Citation: Cardiovascular Diabetology 2011 10:109
  45. There is controversy about the specific pathophysiology of metabolic syndrome (MS) but several authors have argued that hyperinsulinemia is a key feature of the cluster. We aimed to assess whether the baseline...

    Authors: Ki-Chul C Sung, Mi-Hae H Seo, Eun-Jung J Rhee and Andrew M Wilson
    Citation: Cardiovascular Diabetology 2011 10:108
  46. Bone marrow-derived circulating progenitor cells (BM-CPCs) in patients with coronary heart disease are impaired with respect to number and mobilization. However, it is unknown whether the mobilization of BM-CP...

    Authors: Ilkay Bozdag-Turan, R Goekmen Turan, C Hakan Turan, Sophie Ludovicy, Ibrahim Akin, Stephan Kische, Nicole S Arsoy, Henrik Schneider, Jasmin Ortak, Tim Rehders, Tina Hermann, Liliya Paranskaya, Peter Kohlschein, Manuela Bastian, A Tulga Ulus, Kurtulus Sahin…
    Citation: Cardiovascular Diabetology 2011 10:107
  47. The growing prevalence rate of pediatric obesity, which is frequently accompanied by several cardiometabolic risk factors, has become a serious global health issue. To date, little is known regarding differenc...

    Authors: Mariska van Vliet, Martijn W Heymans, Inès A von Rosenstiel, Desiderius PM Brandjes, Jos H Beijnen and Michaela Diamant
    Citation: Cardiovascular Diabetology 2011 10:106

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions